INSIGHTS ON SOLID DOSE MANUFACTURING
-
Safety First: Considerations When Formulating High Potency Compounds
Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.
-
When To Consider Material And Personnel Airlocks For Downflow Booths
Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.
-
Innovations, Solutions, And USP <1062> With Scale Up
Optimize tablet compression by simplifying calibration, speeding up changeovers, and utilizing advanced laser inspection to prevent critical punch tip wear and maintain quality.
-
Paediatric Drug Product Development Through To Commercialisation
Learn how an innovative pediatric minitablet achieved patient-friendly administration, precise dosing and scalable manufacturing to support a smooth path to market.
-
From Early Development To Commercial Launch: An End-To-End Partnership11/5/2026
Bringing a critical therapy to market takes early coordination. See how strategic planning helped accelerate an oncology therapy from clinical development to patients.
-
Advancing High Potency Manufacturing4/13/2026
Advance potent drug manufacturing through tighter containment, thoughtful process engineering, and closed handling that protects workers while improving efficiency and scale.
-
6 Strategic Pillars For Selecting A Drug Packaging Partner4/14/2026
Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.
-
Developing And Manufacturing Drugs With HPAPIs1/27/2025
Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.
-
Reducing Uncertainty In Early Oral Drug Development8/31/2026
Five recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.
SOLID DOSE MANUFACTURING SOLUTIONS
-
GMP drug product manufacturing supports solid dose and sterile parenteral development with formulation expertise, isolator fill‑finish, DEA‑licensed work, packaging, labeling, and supply‑chain services.
-
Mikart offers a wide range of bottle filling options personalized to your needs.
-
ROSS Ribbon Blenders efficiently mix powders, granules, and bulk solids across industries, offering customizable lab-to-production models for various bulk densities, including heavy-duty and sanitary applications.
-
As the pharmaceutical industry innovates and evolves, learn more about how Nanoform can play a critical role in empowering your company's journey to net zero.
-
Learn how single-use isolator technology, purpose-built for ADC manufacturing, eliminates cleaning protocols and delivers containment performance below 10ng/M³.